Home » Posts tagged with » movement disorders
Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal

Novartis to acquire neuroscience company Cadent Therapeutics in $770m worth deal

Novartis acquisition of Cadent Therapeutics : Swiss pharma giant Novartis has agreed to acquire a US neuroscience company Cadent Therapeutics, in a deal worth up to $770 million. The consideration includes an upfront payment of $210 million and up to $560 million in milestone payments. Cadent Therapeutics was launched about three years ago via the […]